Millennium Management’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Other funds holding NRXP
BGI
AI
Millennium Management's NRXP Position: Q2 2026 in Review
Millennium Management opened a new position in NRX Pharmaceuticals (NRXP) in Q2 2026: 12,305 shares worth $50.3K. The stake represents ﹤0.01% of the portfolio and ranks #5609 among its holdings. This is a return to the name: Millennium Management previously reported a position in NRXP as recently as Q4 2024.
Millennium Management first reported a position in NRXP in Q4 2021 and has held it in 5 quarters since. The position peaked at $178K in Q2 2022. 47 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.
- Millennium Management held 12,305 shares of NRX Pharmaceuticals worth $50.3K as of Q2 2026.
- NRX Pharmaceuticals was a new Millennium Management position in Q2 2026.
- NRX Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #5609 holding.
- Millennium Management first reported a position in NRX Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
- Millennium Management's NRX Pharmaceuticals position peaked at $178K in Q2 2022.
- 47 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.